GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Ending Cash Position

G.Barekat Pharm (XTEH:BRKT1) Ending Cash Position : IRR861,629 Mil (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Ending Cash Position?

G.Barekat Pharm's Ending Cash Position for the quarter that ended in Mar. 2017 was IRR861,629 Mil.

G.Barekat Pharm's quarterly Ending Cash Position increased from . 20 (IRR0 Mil) to Mar. 2016 (IRR670,354 Mil) and increased from Mar. 2016 (IRR670,354 Mil) to Mar. 2017 (IRR861,629 Mil).

G.Barekat Pharm's annual Ending Cash Position increased from . 20 (IRR0 Mil) to Mar. 2016 (IRR670,354 Mil) and increased from Mar. 2016 (IRR670,354 Mil) to Mar. 2017 (IRR861,629 Mil).

G.Barekat Pharm Ending Cash Position Historical Data

The historical data trend for G.Barekat Pharm's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Ending Cash Position Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Ending Cash Position
670,354.00 861,629.00

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Ending Cash Position 670,354.00 861,629.00

G.Barekat Pharm Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

G.Barekat Pharm's Ending Cash Position for the fiscal year that ended in Mar. 2017 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=670354+191275
=861,629

G.Barekat Pharm's Ending Cash Position for the quarter that ended in Mar. 2017 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=670354+191275
=861,629

G.Barekat Pharm Ending Cash Position Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Ending Cash Position
Comparable Companies
PRGBQ BOM:532041 PZRXQ NSPX HSTC BOM:540108 XCNQ:ZRO XSAT:EURI B BOM:524604 BOM:532905 VODG BOM:506365 SOAN TSXV:WAVE PTEO BPSR CBBT LSE:PEBI ADYNF NTRR
Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
Website
http://www.bpharmed.com
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines